Adoption of Innovations in Private Alcohol and Drug Treatment Centers in the United States [Restricted-Use], 2009-2013

Adoption of Innovations in Private Alcohol and Drug Treatment Centers is a multi-wave longitudinal study conducted between 2009 and 2013. The study goal was to measure the adoption and implementation of evidence-based treatment practices in treatment centers that received more than 50 percent of their total operational funding from sources that were not guaranteed from year to year. This definition is based on the concept of entrepreneurship, namely the necessity for the treatment organization to respond to changing conditions in the external political and economic environment in order to obtain half or more of its funding. The innovations considered are of three types usually specific to organizations treating substance use disorders: medication-assisted treatments; psychosocial treatments; managerial practices; This data set consists of one of the multiple "waves" of data collection. The data was collected at four points in time. The baseline data, collected from June 2009 through October 2011 from 327 treatment centers, were obtained through face-to-face onsite interviews ranging from 1 to 4 hours in duration. These interviews were conducted with administrators of the respective treatment centers. In 70 of the 327 treatment centers, an administrator of the overall center and the administrator of clinical operations separately completed administrative and clinical interviews. In the remaining 257 centers, all of the administrative and clinical data were collected from the administrator of the overall center since there was no specialized administrator of clinical operations. The baseline data available here merge the data collected through these two different procedures so that the variables measured are identical for all centers regardless of the procedure. The collected data include detailed information on Medication Assisted Treatment (MAT) and other treatment strategies used by the center to treat opioid use disorder (OUD) and alcohol use disorder (AUD). In cases where medications were not used by a center questions were asked for reasons why available medications were not used in treatment. Other sections of the interviews covered data on the organizations, their management, and other clinical practices implemented for OUD, AUD, and substance use disorder (SUD). Three follow-up interviews were conducted via telephone at six month intervals following the previous interview. These follow-up interviews were much shorter compared to the baseline interview. The interviews centered on key changes in the center's operation and on the adoption of key innovations. But a focus of the follow-up interviews still focused on medications provided for treatment.

《私营酒精与药物治疗中心的创新采纳》是一项于2009年至2013年间开展的多波次纵向研究。本研究旨在测算那些运营资金中50%以上来自非年度固定来源的治疗机构，其循证治疗实践的采纳与实施情况。该界定基于创业型组织的核心逻辑：治疗机构需响应外部政治与经济环境的动态变化，以获取半数及以上的运营资金。本次研究关注的创新通常分为三类，针对物质使用障碍治疗机构的专属实践类型：药物辅助治疗（medication-assisted treatments, MAT）、社会心理治疗（psychosocial treatments）以及管理实践（managerial practices）。本数据集为该研究多次数据收集中的一轮。本次研究共开展四轮数据采集：基线数据采集于2009年6月至2011年10月期间，覆盖327家治疗中心，通过时长1至4小时的面对面现场访谈完成，访谈对象为各机构的管理人员。在327家治疗中心中，有70家机构的总中心管理人员与临床运营管理人员分别完成了行政与临床访谈；剩余257家机构未设置专职临床运营管理人员，因此其行政与临床数据均由总中心管理人员采集。本数据集提供的基线数据整合了两种采集流程所得的结果，确保所有中心的测量变量保持一致，不受采集流程差异影响。所收集的数据包含药物辅助治疗（Medication Assisted Treatment, MAT）以及该中心用于治疗阿片类物质使用障碍（opioid use disorder, OUD）与酒精使用障碍（alcohol use disorder, AUD）的其他治疗策略的详细信息。若某中心未使用相关药物，访谈会询问其未采用现有药物开展治疗的原因。访谈的其他板块涵盖机构基本信息、管理模式以及针对OUD、AUD与物质使用障碍（substance use disorder, SUD）实施的其他临床实践相关数据。研究在基线访谈后，以每6个月为间隔开展了三轮电话随访访谈，随访访谈时长远短于基线访谈，主要围绕中心运营的关键变化与核心创新的采纳情况展开，但仍将治疗所用药物作为核心关注内容。